This week's topics include pregnancy outcomes after kidney donation, an AI-integrated model to manage epilepsy, targeting KRAS in cancer therapy, and glucose monitoring in non-insulin users with Type 2 diabetes.
Program notes:
0:35 Continuous glucose monitoring in Type 2 diabetes not using insulin
1:40 Decreased HbA1c
2:35 Already shown to be beneficial in those using insulin
3:30 Cancer vaccines
4:30 Disease-free survival endpoint
5:32 If T-cell population increased
6:30 Pregnancy outcomes in women who donate kidneys
7:30 Matched 4-to-1 with nonkidney donors
8:30 Timing of kidney donation
9:15 AI collaboration for managing epilepsy
10:15 Links EEGs to AI and smartphone app
11:15 Patients requested continuation
12:45 End